CURRICULUM VITAE EDUCATION AND TRAINING
|
|
|
- Abel Dennis
- 10 years ago
- Views:
Transcription
1 CURRICULUM VITAE NAME CURRENT POSITION ADDRESS Dalsan You Clinical Assistant Professor Department of Urology, Asan Medical Center, University of Ulsan College of Medicine 88, Olympic Ro 43 Gil, Songpa Gu, Seoul, , KOREA EDUCATION AND TRAINING Chungnam National University Medicine M.D. (2001) Graduate School, University of Ulsan Medicine M.S. (2008) Graduate School, University of Ulsan Medicine Ph.D. (2011) Asan Medical Center Intern Asan Medical Center Urology Resident Asan Medical Center Urology Clinical Fellow PROFESSIONAL EXPERIENCE Asan Medical Center (Part Time) Clinical Professor SPECIALITY BOARD Korean Board of Urology GCP TRAINING 질병관리본부 [on] 10 RE ( ) 질병관리본부 [on] 13 RE ( )
2 PUBLICATIONS SCI(E) 53. Kim T, Ahn JH, You D, Jeong IG, Hong B, Hong JH, Ahn H, Lee JL. Pulmonary Metastasectomy Could Prolong Overall Survival in Select Cases of Metastatic Urinary Tract Cancer. Clin Genitourin Cancer May 2. [Epub ahead of print] 52. Kim YR, Lee JL, You D, Jeong IG, Song C, Hong B, Hong JH, Ahn H. Gemcitabine plus split dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin unfit patients with advanced urothelial carcinoma. Cancer Chemother Pharmacol May 23. [Epub ahead of print] 51. Kim A, Kwon T, You D, Jeong IG, Go H, Cho YM, Hong JH, Ahn H, Kim CS. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma. J Korean Med Sci Apr;30(4): You D, Jang MJ, Kim BH, Song G, Lee C, Suh N, Jeong IG, Ahn TY, Kim CS. Comparative Study of Autologous Stromal Vascular Fraction and Adipose Derived Stem Cells for Erectile Function Recovery in a Rat Model of Cavernous Nerve Injury. Stem Cells Transl Med Apr;4(4): Kwon T, Jeong IG, Ryu J, Lee C, Lee C, You D, Kim CS. Renal Function is Associated with Nephrometry Score After Partial Nephrectomy: A Study Using Diethylene Triamine Penta Acetic Acid (DTPA) Renal Scanning. Ann Surg Oncol Mar 19. [Epub ahead of print] 48. Park I, Lee JL, Ahn JH, Lee DH, Lee KH, You D, Jeong IG, Song C, Hong B, Hong JH, Ahn H. Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR TKI and mtor inhibitor. Cancer Chemother Pharmacol May;75(5): Han KS, You D, Jeong IG, Kwon T, Hong B, Hong JH, Ahn H, Ahn TY, Kim CS. Is Intravesical Bacillus Calmette Gu?rin Therapy Superior to Chemotherapy for Intermediate risk Non muscle invasive Bladder Cancer?: An Ongoing Debate. J Korean Med Sci Mar;30(3): Lee C, You D, Sohn M, Jeong IG, Song C, Kwon T, Hong B, Hong JH, Ahn H, Kim CS. Prognostic value of ABO blood group in patients with renal cell carcinoma: single institution results from a large cohort. J Cancer Res Clin Oncol Feb 17. [Epub ahead of print] 45. Kwon T, Jeong IG, Yoo S, Lee J, Hong S, You D, Hong JH, Ahn H, Kim CS. Role of MRI in indeterminate renal mass: diagnostic accuracy and impact on clinical decision making. Int Urol Nephrol Feb 14. [Epub ahead of print] 44. Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS. FDG PET CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy. Ann Surg Oncol Jan 30. [Epub ahead of print] 43. Song SH, Jeong IG, You D, Hong JH, Hong B, Song C, Jung WY, Cho YM, Ahn H, Kim CS. VEGF/VEGFR2 and PDGF B/PDGFR β expression in non metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients. Int J Clin Exp Pathol Oct 15;7(11): Kim CS, Kim Y, Kwon T, Yoon JH, Kim KH, You D, Hong JH, Ahn H, Jeong IG. Regulatory T cells and TGF β1 in clinically localized renal cell carcinoma: Comparison with age matched healthy controls. Urol Oncol Dec 10. [Epub ahead of print] 41. Hong S, Kwon T, You D, Jeong IG, Hong B, Hong JH, Ahn H, Kim CS. Incidence of benign results after laparoscopic radical nephroureterectomy. JSLS Oct;18(4). 40. Han KS, Song G, Song C, You D, Jeong IG, Hong JH, Ahn H, Kim CS, Hong B. Comparison of Hand assisted Laparoscopic Versus Robot assisted Laparoscopic Versus Open Partial Nephrectomy in Patients with T1 Renal Masse. J Endourol Oct 29. [Epub ahead of print] 39. You D, Jeong IG, Song C, Lee JL, Hong B, Hong JH, Ahn H, Kim CS. Analysis of pre operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era. Jpn J Clin Oncol Jan;45(1): Kwon T, Jeong IG, Lee J, Lee C, You D, Hong B, Hong JH, Ahn H, Kim CS. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse probability of treatment weighting. J Cancer Res Clin Oncol Aug 14. [Epub ahead of print] 37. Kwon T, Jeong IG, You D, Han KS, Hong S, Hong B, Hong JH, Ahn H, Kim CS. Obesity and prognosis in muscle invasive bladder cancer: The continuing controversy. Int J Urol Nov;21(11):
3 36. Hwang S, Park SK, Lee HY, Kim SW, Lee JS, Choi EK, You D, Kim CS, Suh N. mir 140 5p suppresses BMP2 mediated osteogenesis in undifferentiated human mesenchymal stem cells. FEBS Lett Aug 25;588(17): Park SK, Lee JS, Choi EK, You D, Kim CS, Suh N. Global knockdown of micrornas affects the expression of growth factors and cytokines in human adipose derived mesenchymal stem cells. BMB Rep Aug;47(8): Kwon T, Jeong IG, You D, Hong B, Hong JH, Ahn H, Kim CS. Long term oncologic outcomes after radical cystectomy for bladder cancer at a single institution. J Korean Med Sci May;29(5): Kwon T, Lee JL, Kim JK, You D, Jeong IG, Song C, Ahn H, Kim CS, Hong JH. The Choi response criteria for inferior vena cava tumor thrombus in renal cell carcinoma treated with targeted therapy. J Cancer Res Clin Oncol Oct;140(10): You D, Song SH, Cho YM, Lee JL, Jeong IG, Song C, Hong JH, Kim CS, Ahn H. Predictive role of tissue based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma. World J Urol Jan;33(1): Kwon T, Lee JL, You D, Jeong IG, Song C, Ahn H, Kim CS, Hong JH. Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy. J Surg Oncol Aug;110(2): Kwon T, Jeong IG, Pak S, You D, Song C, Hong JH, Ahn H, Kim CS. Renal tumor size is an independent prognostic factor for overall survival in von Hippel Lindau disease. J Cancer Res Clin Oncol Jul;140(7): Kwon T, Jeong IG, Park M, You D, Lee J, Kim HK, Hong S, Hong JH, Ahn H, Kim CS. Bone Mineral Density in Prostate Cancer: A Comparative Study of Patients With Prostate Cancer and Healthy Controls Using Propensity Score Matching. Urology Feb;83(2): You D, Jeong IG, Song C, Cho YM, Hong JH, Kim CS, Ahn H. High percent tumor volume predicts biochemical recurrence after radical prostatectomy in pathological stage?t3a prostate cancer with a negative surgical margin. Int J Urol May;21(5): Kim Y, Jeong IG, You D, Song SH, Suh N, Jang SW, Kim S, Hwang JJ, Kim CS. Sodium meta arsenite induces reactive oxygen species dependent apoptosis, necrosis, and autophagy in both androgen sensitive and androgen insensitive prostate cancer cells. Anticancer Drugs Jan;25(1): Jeong IG, You D, Yoon JH, Hong S, Lim JH, Hong JH, Choo MS, Ahn H, Kim CS. Impact of tamsulosin on urinary retention following early catheter removal after robot assisted laparoscopic radical prostatectomy: A prospective randomized controlled trial. Int J Urol Feb;21(2): Jeong IG, Lim JH, You D, Kim MH, Choi HJ, Kim JK, Cho KS, Hong JH, Ahn H, Kim CS. Incremental Value of MRI in Clinically High risk Prostate Cancer: A Large Single institution Experience of 922 Radical Prostatectomy. J Urol Dec;190(6): Hong S, Jeong IG, You D, Lee JL, Hong JH, Ahn H, Kim CS. Safety of megestrol acetate in palliating anorexia cachexia syndrome in patients with castration resistant prostate cancer. J Korean Med Sci May;28(5): Lim JH, You D, Jeong IG, Park HK, Ahn H, Kim CS. Cystoscopic injection of N butyl 2 cyanoacrylate followed by fibrin glue for the treatment of persistent or massive vesicourethral anastomotic urine leak after radical prostatectomy. Int J Urol Oct;20(10): You D, Jang MJ, Lee J, Jeong IG, Kim HS, Moon KH, Suh N, Kim CS. Periprostatic Implantation of Human Bone Marrow derived Mesenchymal Stem Cells Potentiates Recovery of Erectile Function by Intracavernosal Injection in a Rat Model of Cavernous Nerve Injury. Urology Jan;81(1): Lee C, Kim KH, You D, Jeong IG, Hong B, Hong JH, Ahn H, Kim CS. Smoking and Survival After Radical Cystectomy for Bladder Cancer. Urology Dec;80(6): Song HY, Kim CS, Jeong IG, Yoo D, Kim JH, Nam DH, Bae JI, Park JH. Placement of retrievable self expandable metallic stents with barbs into patients with obstructive prostate cancer. Eur Radiol Mar;23(3): Kim KH, You D, Jeong IG, Kwon TW, Cho YM, Hong JH, Ahn H, Kim CS. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus. BJU Int Dec;110(11 Pt B):E673 8.
4 18. You D, Hong S, Lee C, Kim KS. Feasibility and Safety of Laparoscopic Ablative Renal Surgery in Infants: Comparative Study with Children. J Urol Oct;188(4): You D, Jang MJ, Lee J, Suh N, Jeong IG, Sohn DW, Kim SW, Ahn TY, Kim CS. Comparative analysis of periprostatic implantation and intracavernosal injection of human adipose tissue derived stem cells for erectile function recovery in a rat model of cavernous nerve injury. Prostate Feb 15;73(3): Kim CS, You D, Jeong IG. Can robotic surgery be a standard procedure in the treatment of prostate cancer? J Korean Med Assoc Jul;55(7): Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Muscle invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. Urol Oncol May 14. [Epub ahead of print] 14. Kim KH, You D, Jeong IG, Song C, Hong JH, Ahn H, Kim CS. The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma. J Cancer Res Clin Sep;138(9): Jeong IG, You D, Kim J, Kim SC, Hong JH, Ahn H, Kim CS. Does Factors associated with non orthotopic urinary diversion after radical cystectomy. World J Urol Dec;30(6): Park M, You D, Yoon JH, Jeong IG, Song C, Hong JH, Ahn H, Kim CS. Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? analysis by the number of cores taken at initial biopsy. BJU Int May;109(10): You D, Shim M, Jeong IG, Kim JK, Ro JY, Hong JH, Ahn H, Kim CS. The multilocular cystic renal cell carcinoma: clinico pathologic features and preoperative prediction using multiphase computerized tomography. BJU Int Nov;108(9): Jeong IG, You D, Kim JW, Song C, Hong JH, Ahn H, Kim CS. Outcomes of single lymph node positive urothelial carcinoma after radical cystectomy. J Urol Jun;185(6): You D, Jeong IG, Ahn JH, Lee DH, Lee JL, Hong JH, Ahn H, Kim CS. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy. J Urol Jan;185(1): Jeong IG, Ro JY, Kim SC, You D, Song C, Hong JH, Ahn H, Kim CS. Extranodal extension in node positive bladder cancer: the continuing controversy. BJU Int Jul;108(1): Jeong IG, Kim JK, Cho KS, You D, Song C, Hong JH, Ahn H, Kim CS. Diffusion Weighted Magnetic Resonance Imaging in Patients With Unilateral Prostate Cancer on Extended Prostate Biopsy: Predictive Accuracy of Laterality and Implications for Hemi Ablative Therapy. J Urol Nov;184(5): You D, Jeong IG, Kim SW, Chung BH, Cho JS, Lee HM, Yun SC, Kim CS. Impacts of leuprolide acetate on quality of life in patients with prostate cancer: A prospective multicenter study. Scand J Urol Nephrol Dec;44(6): You D, Kim SC, Jeong IG, Hong JH, Ro JY, Ahn H, Kim CS. Urothelial carcinoma of the bladder with seminal vesicle invasion: prognostic significance. BJU Int Dec;106(11): You D, Park J, Hong B, Park HK. Effect of output voltage distribution on stone comminution efficiency during shockwave lithotripsy in renal or ureteropelvic junction stones: A preliminary study. Scand J Urol Nephrol Sep;44(4): Kwon T, Jeong IG, You D, Park MC, Hong JH, Ahn H, Kim CS. Effect of prostate size on pathological outcome and biochemical recurrence after radical prostatectomy for prostate cancer: is it correlated with serum testosterone level? BJU Int Sep;106(5): You D, Bang JK, Shim M, Ryu DS, Kim KS. Analysis of the late outcome of laparoscopic heminephrectomy in children with duplex kidneys. BJU Int Jul;106(2): Song SH, Lee SB, Yoo DS, Kim KS. Fluoroscopy assisted retroperitoneal laparoscopic renal surgery in children. J Endourol Apr;20(4):256 9.
5 OTHERS 25. Kwon T, Jeong IG, You D, Hong JH, Ahn H, Kim CS. Prevalence and clinical significance of incidental (18)F fluoro 2 deoxyglucose uptake in prostate. Korean J Urol Apr;56(4): Lim B, You D, Jeong IG, Kwon T, Hong S, Song C, Cho YM, Hong B, Hong JH, Ahn H, Kim CS. Clinicopathological features of Xp11.2 translocation renal cell carcinoma. Korean J Urol Mar;56(3): Sohn M, Kwon T, Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS. Histologic variability and diverse oncologic outcomes of prostate sarcomas. Korean J Urol Dec;55(12): Kyung YS, You D, Kwon T, Song SH, Jeong IG, Song C, Hong B, Hong JH, Ahn H, Kim CS. The type of nephrectomy has little effect on overall survival or cardiac events in patients of 70 years and older with localized clinical t1 stage renal masses. Korean J Urol Jul;55(7): Lim JH, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Prognosis of prostate cancer with other primary malignancies. Korean J Urol May;55(5): Pak S, Park S, Ryu J, Hong S, Song SH, You D, Jeong IG, Song C, Hong JH, Kim CS, Ahn H. Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean J Urol Dec;54(12): Ryu J, Kwon T, Kyung YS, Hong S, You D, Jeong IG, Kim CS. Retropubic Versus Robot Assisted Laparoscopic Prostatectomy for Prostate Cancer: A Comparative Study of Postoperative Complications. Korean J Urol Nov;54(11): Song G, Lee C, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Prostate specific antigen response rate of sequential chemotherapy in castration resistant prostate cancer: the results of real life practice. Prostate Int. 2013;1(3): Jeong IG, Lim JH, Hwang SS, Kim SC, You D, Hong JH, Ahn H, Kim CS. Nomogram using transrectal ultrasound derived information predicting the detection of high grade prostate cancer on initial biopsy. Prostate Int. 2013;1(2): You D, Hong JH. Rare Cause of Hydronephrosis. Korean J Urol Mar 054(03): Choi D, Kim D, Kyung YS, Lim JH, Song SH, You D, Jeong IG, Kim CS. Clinical experience with limited lymph node dissection for prostate cancer in Korea: single center comparison of 247 open and 354 robot assisted laparoscopic radical prostatectomy series. Korean J Urol Nov;53(11): Kim D, Choi D, Lim JH, Yoon JH, Jeong IG, You D, Hong JH, Ahn H, Kim CS. Changes in Prostate Cancer Aggressiveness over a 12 Year Period in Korea. Korean J Urol Oct;53(10): You D, Kim CS. Stem Cell Therapy for Erectile Dysfunction Following Radical Prostatectomy: From Bench to Bed. Journal of the Association of Stem Cell and Tissue Regeneration Dec;1(1): Lee C, You D, Park J, Jeong IG, Song C, Hong JH, Ahn H, Kim CS. Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index. Korean J Urol Aug;52(8): Yoo S, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Does Radical Cystectomy Improve Overall Survival in Octogenarians with Muscle Invasive Bladder Cancer? Korean J Urol Jul;52(7): You D, Jeong IG, Kim CS. Role of radical prostatectomy for high risk prostate cancer. Korean J Urol Sep;51(9): Epub 2010 Sep Hong S, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Analysis of the Clinical Features of Patients with Metastatic Spinal Cord Compression Caused by Prostate Cancer. Korean J Urol 2009 Dec;50(12): You D, Shim M, Kim SC, Ha SH, Kwon T, Kim KS. Transperitoneal Laparoscopic Upper Pole Heminephrectomy in Pediatric Patients with Duplex Kidneys: Comparison with an Age Matched Cohort of Open Surgery. Korean J Urol 2009 Sep;50(9): You D, Bang JK, Kim KS. Analysis of the Learning Curve for Laparoscopic Renal Surgeries in Children. Korean J Urol 2009 Apr;50(4): You D, Kim KS. Selection of Approach Method during Laparoscopic Renal Surgeries in Pediatric Patients. Korean J Urol 2007 Mar;48(3): Song SH, Hong B, You D, Ahn TY. Vardenafil Improves Lower Urinary Tract Symptoms in Patients of Erectile Dysfunction. Kor J Androl 2006;24: You D, Park T, Park HK. Endourologic Management for Calyceal Diverticular Stone. Korean J Urol 2005 Feb;46(2): Song C, Kang T, You D, Hong JH, Ahn H. Expression of Bcl 2 and Bax in cis Diamminedichloroplatinum (II) Resistant Bladder Cancer Cell Lines. Korean J Urol 2004 May;45(5):472 7.
6 2. You D, Hong B, Park JY, Ahn TY. Risk Factors for Development of Long term Complications after Surgical Repair of Penile Fracture.KorJAndrol.2004;22: Song SH, Ji YH, Lee SB, You D, Kim JK, Park JY, Ahn H, Kim CS. A Prospective Randomized Study Comparing Effectiveness of Local Anesthesia Techniques in Patients undergoing Transrectal Ultrasound guided Prostate Biopsy. Korean J Urol 2004 Mar;45(3):236 9.
These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.
Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of
Historical Basis for Concern
Androgens After : Are We Ready? Mohit Khera, MD, MBA Assistant Professor of Urology Division of Male Reproductive Medicine and Surgery Scott Department of Urology Baylor College of Medicine Historical
CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014
Background CMScript Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014 Prostate cancer is second only to lung cancer as the leading cause of cancer-related deaths in men. It is
Guidelines for Management of Renal Cancer
Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated
Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical
Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies
Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
Kidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
Implementation Date: April 2015 Clinical Operations
National Imaging Associates, Inc. Clinical guideline PROSTATE CANCER Original Date: March 2011 Page 1 of 5 Radiation Oncology Last Review Date: March 2015 Guideline Number: NIA_CG_124 Last Revised Date:
Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer
Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer David Josephson, MD FACS Fellowship Director, Urologic Oncology and Robotic Surgery Program Staging Most important in risk assessment and
Prostate Cancer. Treatments as unique as you are
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma
窑 Original Article 窑 Chinese Journal of Cancer Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma Zhi Ling Zhang,2, Yong Hong Li,2, Yong Hong Xiong 3, Guo Liang Hou,2,
Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery
Facing Prostate Cancer Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Prostate Cancer Your prostate is a walnut-sized gland that is part of the male reproductive system. The prostate
PSA Screening for Prostate Cancer Information for Care Providers
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
DIAGNOSIS OF PROSTATE CANCER
DIAGNOSIS OF PROSTATE CANCER Determining the presence of prostate cancer generally involves a series of tests and exams. Before starting the testing process, the physician will ask questions about the
Does my patient need more therapy after prostate cancer surgery?
Does my patient need more therapy after prostate cancer surgery? Contact the GenomeDx Patient Care Team at: 1.888.792.1601 (toll-free) or e-mail: [email protected] Prostate Cancer Classifier
7. Prostate cancer in PSA relapse
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward
Update on Prostate Cancer: Screening, Diagnosis, and Treatment Making Sense of the Noise and Directions Forward 33 rd Annual Internal Medicine Update December 5, 2015 Ryan C. Hedgepeth, MD, MS Chief of
2016 Mayo Clinic Urology Review
2016 Mayo Clinic Urology Review Please note that all times and speakers are subject to change. All sessions located in Grand Ballroom 2-5 unless otherwise noted. MONDAY, JANUARY 25, 2016 6:00 a.m. - 11:00
Us TOO University Presents: Understanding Diagnostic Testing
Us TOO University Presents: Understanding Diagnostic Testing for Prostate Cancer Patients Today s speaker is Manish Bhandari, MD Program moderator is Pam Barrett, Us TOO International Made possible by
Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence. Cord Sturgeon, MD
Thyroid Cancer: Resection, Dissection, Surveillance and Recurrence Cord Sturgeon, MD Associate Professor of Surgery Northwestern University Feinberg School of Medicine Director of Endocrine Surgery Chicago,
SMALL CELL LUNG CANCER
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
Name (Youngsook Son) Education Major Activities
CV Name (Youngsook Son) Affiliation: Dept of Genetic Engineering and Graduate School of Biotechnology, Kyung Hee University Address : 1 Seochun dong, Kiheung Gu, Yong In, Korea Email : [email protected]
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC)
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC) FDA Presentation ODAC Meeting September 14, 2011 1 Review Team Paul G. Kluetz,
Clinical Management Guideline Management of locally advanced or recurrent Renal cell carcinoma. Protocol for Planning and Treatment
Protocol for Planning and Treatment The process to be followed in the management of: LOCALLY ADVANCED OR METASTATIC RENAL CELL CARCINOMA Patient information given at each stage following agreed information
Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data
The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
Prostate Cancer Treatment: What s Best for You?
Prostate Cancer Treatment: What s Best for You? Prostate Cancer: Radiation Therapy Approaches I. Choices There is really a variety of options in prostate cancer management overall and in radiation therapy.
Beyond the PSA: Genomic Testing in Localized Prostate Cancer
Beyond the PSA: Genomic Testing in Localized Prostate Cancer Kelvin A. Moses, MD, PhD Vanderbilt University Medical Center Wednesday, December 2, 2015 5:00 p.m. ET/2:00 p.m. PT About ZERO ZERO s mission
Precise, Minimally Invasive Prostate Cancer Removal
Precise, Minimally Invasive Prostate Cancer Removal Learn why da Vinci Surgery may be your best treatment option 1 Beyond Minimally Invasive For Prostate Cancer 1 Facing Prostate Cancer Prostate cancer
Understanding the. Controversies of. testosterone replacement. therapy in hypogonadal men with prostate cancer. controversies surrounding
Controversies of testosterone replacement therapy in hypogonadal men with prostate cancer Samuel Deem, DO CULTURA CREATIVE (RF) / ALAMY Understanding the controversies surrounding testosterone replacement
Medullary Renal Cell Carcinoma Case Report
Bahrain Medical Bulletin, Vol. 27, No. 4, December 2005 Medullary Renal Cell Carcinoma Case Report Mohammed Abdulla Al-Tantawi MBBCH, CABS* Abdul Amir Issa MBBCH, CABS*** Mohammed Abdulla MBBCH, CABS**
Clinical Practice Assessment Robotic surgery
Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA) Merat Esfahani, MD Medical Oncologist, Hematologist Cancer Liaison Physician SwedishAmerican Regional Cancer Center
Thomas A. Kollmorgen, M.D. Oregon Urology Institute
Thomas A. Kollmorgen, M.D. Oregon Urology Institute None 240,000 new diagnosis per year, and an estimated 28,100 deaths (2012) 2 nd leading cause of death from cancer in U.S.A. Approximately 1 in 6 men
The 4Kscore blood test for risk of aggressive prostate cancer
The 4Kscore blood test for risk of aggressive prostate cancer Prostate cancer tests When to use the 4Kscore Test? Screening Prior to 1 st biopsy Prior to negative previous biopsy Prognosis in Gleason 6
An Introduction to PROSTATE CANCER
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
PSA screening: Controversies and Guidelines
PSA screening: Controversies and Guidelines John Phillips, MD, FACS Department of Urology Urology Center of Westchester New York Medical College Historical PerspecGve Cancer of the prostate, although rare,
Advances in Diagnostic and Molecular Testing in Prostate Cancer
Advances in Diagnostic and Molecular Testing in Prostate Cancer Ashley E. Ross MD PhD Assistant Professor Urology, Oncology, Pathology Johns Hopkins School of Medicine September 24, 2015 1 Disclosures
PROSTATE CANCER. Get the facts, know your options. Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology
PROSTATE CANCER Get the facts, know your options Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology i What is the Prostate? Unfortunately, you have prostate
Early Prostate Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
How To Treat A Uterine Sarcoma
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition 2001 Uterus: Uterine Sarcomas Jeffrey L. Stern, MD Uterine sarcomas
Lung Cancer Treatment Guidelines
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery
Facing a Hysterectomy? If you ve been diagnosed with early stage gynecologic cancer, learn about minimally invasive da Vinci Surgery The Condition: Early Stage Gynecologic Cancer A variety of gynecologic
Prostate Cancer In-Depth
Prostate Cancer In-Depth Introduction Prostate cancer is the most common visceral malignancy among American men. In the year 2003, there are expected to be 220,000 new cases and nearly 29,000 deaths in
Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka
Adiuwantowe i neoadiuwantowe leczenie chorych na zaawansowanego raka żołądka Neoadiuvant and adiuvant therapy for advanced gastric cancer Franco Roviello, IT Neoadjuvant and adjuvant therapy for advanced
Prostate Cancer Action Plan: Choosing the treatment that s right for you
Prostate Cancer Action Plan: Choosing the treatment that s right for you Segment 1: Introduction Trust me, there's a better way to choose a treatment for your prostate cancer. Watching this program is
PROSTATE CANCER 101 WHAT IS PROSTATE CANCER?
PROSTATE CANCER 101 WHAT IS PROSTATE CANCER? Prostate cancer is cancer that begins in the prostate. The prostate is a walnut-shaped gland in the male reproductive system located below the bladder and in
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
Report series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
How To Know If You Should Get A Brachytherapy Or Radioactive Seed Implantation
MEDICAL POLICY SUBJECT: BRACHYTHERAPY OR PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy
NERVE GRAFT TO RESTORE ERECTILE FUNCTION DURING RADICAL PROSTATECTOMY
CLINICAL POLICY NERVE GRAFT TO RESTORE ERECTILE FUNCTION DURING RADICAL PROSTATECTOMY Policy Number: SURGERY 043.13 T Effective Date: October 1, 015 Table of Contents BENEFIT CONSIDERATIONS. APPLICABLE
Metastatic Prostate Cancer Causing Complete Obstruction of the IVC
Department of Radiology Henry Ford Health System Detroit, Michigan Metastatic Prostate Cancer Causing Complete Obstruction of the IVC Jennifer Johnston MSIII, Wayne State Medical School Stage 4 Metastatic
Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2228475/ Avastin (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 Description: Avastin (Renal Cell Carcinoma) Analysis and
PSA Testing 101. Stanley H. Weiss, MD. Professor, UMDNJ-New Jersey Medical School. Director & PI, Essex County Cancer Coalition. weiss@umdnj.
PSA Testing 101 Stanley H. Weiss, MD Professor, UMDNJ-New Jersey Medical School Director & PI, Essex County Cancer Coalition [email protected] September 23, 2010 Screening: 3 tests for PCa A good screening
HEALTH NEWS PROSTATE CANCER THE PROSTATE
HEALTH NEWS PROSTATE CANCER THE PROSTATE Prostate comes from the Greek meaning to stand in front of ; this is very different than prostrate which means to lie down flat. The prostate is a walnut-sized
Prostate Cancer Treatment Comparison
Prostate Cancer Treatment Comparison Treatment Comparative Data Outcome Comparison: Surgery vs. Radiotherapy Outcome Radical Prostatectomy* Radiation** Survival duration compared to conservative disease
Translocation Renal Cell Carcinomas
Translocation Renal Cell Carcinomas Cora N. Sternberg, MD, FACP Chair, Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy Kidney cancer is not a single disease Clear cell (75%)
A912: Kidney, Renal cell carcinoma
A912: Kidney, Renal cell carcinoma General facts of kidney cancer Renal cell carcinoma, a form of kidney cancer that involves cancerous changes in the cells of the renal tubule, is the most common type
Aggressive lymphomas. Michael Crump Princess Margaret Hospital
Aggressive lymphomas Michael Crump Princess Margaret Hospital What are the aggressive lymphomas? Diffuse large B cell Mediastinal large B cell Anaplastic large cell Burkitt lymphoma (transformed lymphoma:
Adjuvant Therapy for Breast Cancer: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Adjuvant Therapy for Breast
A918: Prostate: adenocarcinoma
A918: Prostate: adenocarcinoma General facts of prostate cancer The prostate is about the size of a walnut. It is just below the bladder and in front of the rectum. The tube that carries urine (the urethra)
Small cell lung cancer
Small cell lung cancer Small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing organs that are found within
1. What is the prostate-specific antigen (PSA) test?
1. What is the prostate-specific antigen (PSA) test? Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. The doctor
New Data Supporting Modified RECIST (mrecist) for Hepatocellular Carcinoma. Running Title: Modified RECIST (mrecist) for Hepatocellular Carcinoma
New Data Supporting Modified RECIST (mrecist) for Hepatocellular Carcinoma Running Title: Modified RECIST (mrecist) for Hepatocellular Carcinoma Riccardo Lencioni Author s Affiliation: Division of Diagnostic
بسم هللا الرحمن الرحيم
بسم هللا الرحمن الرحيم Updates in Mesothelioma By Samieh Amer, MD Professor of Cardiothoracic Surgery Faculty of Medicine, Cairo University History Wagner and his colleagues (1960) 33 cases of mesothelioma
Prostate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40.
A.D.A.M. Medical Encyclopedia. Prostate cancer Cancer - prostate; Biopsy - prostate; Prostate biopsy; Gleason score Last reviewed: October 2, 2013. Prostate cancer is cancer that starts in the prostate
Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery
Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David
Radiotherapy in Plasmacytoma and Myeloma. David Cutter Multiple Myeloma NSSG Annual Meeting 14 th September 2015
Radiotherapy in Plasmacytoma and Myeloma David Cutter Multiple Myeloma NSSG Annual Meeting 14 th September 2015 Contents Indications for radiotherapy: Palliation in Multiple Myeloma Solitary Bone Plasmacytoma
ANDREW CALLAWAY JAMES, MD
ANDREW CALLAWAY JAMES, MD Personal Information: UNIVERSITY OF KENTUCKY COLLEGE OF MEDICINE DEPARTMENT OF UROLOGY CurriculumVitae Office Address: University of Kentucky 800 Rose Street Room MS269 Lexington,
Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules)
Thyroid Differentiated Cancer: Does Size Really Count? (New ways to evaluate thyroid nodules) Jeffrey S. Freeman, D.O., F.A.C.O.I. Chairman, Division of Endocrinology and Metabolism Philadelphia College
Something Old, Something New.
Something Old, Something New. Michelle A. Fajardo, D.O. Loma Linda University Medical Center Clinical Presentation 6 year old boy, presented with hematuria Renal mass demonstrated by ultrasound & CT scan
Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer
Protein kinase C alpha expression and resistance to neo-adjuvant gemcitabine-containing chemotherapy in non-small cell lung cancer Dan Vogl Lay Abstract Early stage non-small cell lung cancer can be cured
Stage I, II Non Small Cell Lung Cancer
Stage I, II Non Small Cell Lung Cancer Best Results T1 (less 3 cm) N0 80% 5 year survival No Role Adjuvant Chemotherapy Radiation Therapy Reduces Local Recurrence No Improvement in Survival 1 Staging Mediastinal
The TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
da Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy)
da Vinci Prostatectomy Information Guide (Robotically-Assisted Radical Prostatectomy) Prostate Cancer Overview Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the
Combined Harvard Urologic Oncology Fellowship Program
Combined Harvard Urologic Oncology Fellowship Program 1 Goal: Department of Urology To reduce the disease burden for patients with urologic issues by improving: Clinical Care Teaching Research 2 History
CancerStemCell Markers in Lung Cancers: Proofsof. Reservations. Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany
CancerStemCell Markers in Lung Cancers: Proofsof ConceptsandSome Reservations Lourdes Cortes-Dericks, PhD University of Hamburg Hamburg, Germany Lung cancer: highest death rate and poorest patient survival
Brian Louis Cohen, M.D., M.P.H.
Brian Louis Cohen, M.D., M.P.H. MEDICAL TRAINING Fellowship in Female Urology, Voiding Dysfunction, and Reconstructive Urology Anticipated, July 2007 June 2008 Residency in Urology, July 2003 June 2007
Robert Bristow MD PhD FRCPC
Robert Bristow MD PhD FRCPC Clinician-Scientist and Professor, Radiation Oncology and Medical Biophysics, University of Toronto and Ontario Cancer Institute/ (UHN) Head, PMH-CFCRI Prostate Cancer Research
Intravesical Therapy for Bladder Cancer
Intravesical Therapy for Bladder Cancer Norm D. Smith, M.D. Chief of Urologic Oncology Department of Urology Northwestern University Feinberg School of Medicine The Problem Bladder cancer Superficial disease
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
Radiation Therapy for Prostate Cancer
Radiation Therapy for Prostate Cancer Introduction Cancer of the prostate is the most common form of cancer that affects men. About 240,000 American men are diagnosed with prostate cancer every year. Your
THYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); [email protected] Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.
The Center for Prostate Cancer Personalized Treatment. Clinical Excellence. The Center for Prostate Cancer Leaders in Prostate Cancer Treatment and Research The Center for Prostate Cancer at the North
male sexual dysfunction
male sexual dysfunction lack of desire Both men and women often lose interest in sex during cancer treatment, at least for a time. At first, concern for survival is so overwhelming that sex is far down
Lung cancer is not just one disease. There are two main types of lung cancer:
1. What is lung cancer? 2. How common is lung cancer? 3. What are the risk factors for lung cancer? 4. What are the signs and symptoms of lung cancer? 5. How is lung cancer diagnosed? 6. What are the available
Cancer of the Cardia/GE Junction: Surgical Options
Cancer of the Cardia/GE Junction: Surgical Options Michael A Smith, MD Associate Chief Thoracic Surgery Center for Thoracic Disease St Joseph s Hospital and Medical Center Phoenix, AZ Michael Smith, MD
OBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
POLICY A. INDICATIONS
Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT
1400 Telegraph Bloomfield Hills, MI 48302 248-334-6877-Phone number/248-334-6877-fax Number CANCER TREATMENT Learning that your pet has a diagnosis of cancer can be overwhelming. We realize that your pet
